Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Usability of the EXPLORER Exoskeleton · Neurodevelopmental Disorders in Natural Environments Primary completion pushed from Apr 1, 2025 to Aug 1, 2026
- Notable: Lubricin-inspired Osteoarthritis Treatment: a Unique Solution Primary completion pushed from Jun 2027 to Mar 2028
- Notable: Juläine (TM) · Atrophic Facial Acne Scars Primary completion pushed from Dec 2026 to Jan 2028
- Notable: Acellular Dermal Matrix Investigation in Breast Reconstruction Primary completion pushed from Dec 2026 to Dec 2027
- Notable: Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis Primary completion pushed from Jun 1, 2026 to Sep 1, 2027
- Notable: HEARTFELT Study Primary completion pushed from Jan 1, 2028 to Dec 31, 2028
- Notable: Juläine™ in Improving Gluteal Skin Laxity in Adults Primary completion pushed from Apr 2027 to Jan 2028
- Notable: AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery Primary and study completion pushed from Mar 2026 to Dec 2027
- Notable: PGx Medication Safety Reviews · IDD Primary completion pushed from Jul 31, 2027 to Jul 31, 2028
- Notable: Multicentric Pilot Study for the Application of an Endourethral Device · Stress Urinary Incontinence Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027
- Notable: Imatinib to Increase RUNX1 Activity · Germline RUNX1 Deficiency Primary completion pushed from Oct 30, 2026 to Oct 30, 2027
- Notable: Reduced Port Laparoscopic Gastrectomy for Gastric Cancer Primary and study completion pushed from Mar 1, 2027 to Mar 1, 2029
- Notable: TTF-NGR Randomized Study - STS Primary completion pushed from Aug 2026 to Dec 2030
- Notable: Treatment of Post-Stroke Central Pain Primary and study completion pushed from Aug 1, 2026 to Aug 1, 2029
- Notable: Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy Primary completion pushed from Sep 1, 2026 to Dec 1, 2027
- Notable: Estrogen Supplementation and Bone Health · CF Primary completion pushed from Jan 2027 to Jan 2028
- Notable: Fisetin to Reduce Senescence and Mobility Impairment in PAD Primary completion pushed from Nov 2026 to Jun 30, 2027
- Notable: 6 Hour Oxaliplatin Infusions · Gastrointestinal Cancers Primary completion pushed from Aug 5, 2026 to Aug 5, 2027
- Notable: Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients Primary completion pushed from Jun 1, 2026 to Jan 1, 2027
- Notable: COMS for Chronic Ulcers Treatment Primary completion pushed from Aug 31, 2026 to Aug 31, 2027
- Notable: Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM Primary completion pushed from Mar 15, 2025 to Nov 15, 2026
- Notable: NUC-7738 · Advanced Solid Tumours and Lymphoma Primary and study completion pushed from Aug 2026 to Jul 2027
- Notable: Ethnic Differences in Mechanisms of Action of Dupilumab Primary completion pushed from Dec 2026 to Jul 2027
- Notable: Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study Primary and study completion pushed from Dec 2026 to Oct 2027
- Notable: Third-Party Natural Killer Cells and Mogamulizumab · Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma Primary completion pushed from Oct 30, 2026 to Jul 30, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates